Loading…
Wednesday May 14, 2025 2:45pm - 3:05pm EDT
The path to successful new drug development is increasingly complex, marked by scientific challenges, diverse regulatory requirements, and constrained resources—pressures felt especially acutely by start-up biotech companies. Drawing on experience from thousands of early-phase projects, this presentation will explore critical considerations for early-phase API and formulation R&D from a CDMO perspective. We will highlight key strategies to streamline development processes, optimize resource utilization, and accelerate the transition from discovery to development, ultimately enabling faster and more efficient IND filings.


Speakers
avatar for Dr. Jim Li

Dr. Jim Li

President of Global CMC Solutions, BioDuro
Dr. Jim Li joined BioDuro from a twelve-year tenure at the legacy company Sundia MediTech, where he held multiple leadership roles, including CEO and CTO. Before BioDuro, Jim held leadership positions at global pharmaceutical companies including Pfizer and Henkel. Throughout his... Read More →
Wednesday May 14, 2025 2:45pm - 3:05pm EDT

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link